GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » LCA-Vision Inc (FRA:LCV1) » Definitions » Total Equity

LCA-Vision (FRA:LCV1) Total Equity : €13.63 Mil (As of Mar. 2014)


View and export this data going back to . Start your Free Trial

What is LCA-Vision Total Equity?

LCA-Vision's total equity for the quarter that ended in Mar. 2014 was €13.63 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


LCA-Vision Total Equity Historical Data

The historical data trend for LCA-Vision's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LCA-Vision Total Equity Chart

LCA-Vision Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.01 23.53 19.96 15.09 13.97

LCA-Vision Quarterly Data
Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.23 16.42 15.32 13.97 13.63

LCA-Vision Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

LCA-Vision's Total Equity for the fiscal year that ended in Dec. 2013 is calculated as

Total Equity=Total Assets(Q: Dec. 2013 )-Total Liabilities(Q: Dec. 2013 )
=31.328-17.362
=13.97

LCA-Vision's Total Equity for the quarter that ended in Mar. 2014 is calculated as

Total Equity=Total Assets(Q: Mar. 2014 )-Total Liabilities(Q: Mar. 2014 )
=31.783-18.149
=13.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LCA-Vision Total Equity Related Terms

Thank you for viewing the detailed overview of LCA-Vision's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


LCA-Vision (FRA:LCV1) Business Description

Traded in Other Exchanges
N/A
Address
LCA-Vision, Inc., is a provider of fixed-site laser vision correction services at its LasikPlus vision centers. Its vision centers provide the staff, facilities, equipment and support services for performing laser vision correction that employ advanced laser technologies to help correct nearsightedness, farsightedness and astigmatism. Its vision centers are supported by ophthalmologists and credentialed optometrists, as well as other healthcare professionals. The ophthalmologists perform the laser vision correction procedures in its vision centers, and ophthalmologists or optometrists conduct pre-procedure evaluations and post-operative follow-up care in-center. It provides two types of procedures in its vision centers namely LASIK; and PRK and Surface Ablation. It began performing LASIK, in 1996, which continues to account for the majority of the laser vision correction procedures performed in the United States. In LASIK procedures, its surgeon's uses a femtosecond laser to create a thin flap, which remains hinged to the eye. In PRK procedures, the ophthalmologist removes the thin layer of cells covering the outer surface of the cornea (the epithelium) in order to apply the excimer laser pulses directly to the surface of the cornea. Following the PRK procedure, the ophthalmologist places a bandage contact lens on the eye to protect it. Most of its patients currently receive a procedure called laser-assisted in situ keratomileusis ('LASIK'), which it began performing in the United States in 1996. As of December 31, 2012, it operated 54 LasikPlus fixed-site laser vision correction centers generally located in metropolitan markets in the United States, including two vision centers licensed to ophthalmologists who operate using its trademarks. It currently uses two suppliers for its fixed-site excimer lasers: Abbott Medical Optics ('AMO') and Alcon Inc. ('Alcon'). Its business is heavily dependent on advertising, which is subject to regulation by the Federal Trade Commission ('FTC').

LCA-Vision (FRA:LCV1) Headlines

No Headlines